The goal of the 13th Annual BIO Investor Forum is to bring together early and established private companies, as well as emerging public companies, with top private and public equity investors. Presentations are a key programming element, and allow companies to discuss their pipeline, R&D activities, and future goals to this exclusive audience, fostering the development of important new medicines that will expand the industry’s pipeline.
Companies interested in presenting must have a clear R&D focus, with a pipeline involving biotechnology therapeutics, diagnostics, or platform technologies. Service providers will not be considered. For questions about company presentations, please read our FAQ here.
To submit an application, please complete the form below. You will receive an email regarding the status of your application in the coming weeks. The deadline to submit an application is September 9th, 2014.
Only the Company Description and Therapeutic Area of Focus may be used in conference materials. Other information below is used for selection purposes only and will not be printed in conference handbooks, or as profiles for the partnering system.